FDA DEVICE FACTS
Powder Free Blue Nitrile Examination Gloves, Tested for Use with Chemotherapy Drugs
Hebei Titans Hongsen Medical Technology Co., Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Powder Free Blue Nitrile Examination Gloves, Tested for Use with Chemotherapy Drugs is a disposable device intended for medical purposes that is worn on the examiner’s hands to prevent contamination between patient and examiner. The proposed device was tested for use with Chemotherapy Drugs as per ASTM D6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs: Chemotherapy Drug Permeation The following chemicals have been tested with proposed device. Chemotherapy Drug Concentration Breakthrough Detection Time in Minutes Bleomycin 15 mg/ml (15,000 ppm) >240 Busulfan 6 mg/ml (6,000 ppm) >240 Carboplatin 10 mg/ml (10,000ppm) >240 Carmustine (BCNU) 3.3 mg/ml (3,300ppm) 8.5 (12.7, 13.4, 8.5) Cisplatin 1.0 mg/ml (1,000ppm) >240 Cyclophosphamide(Cytoxan) 20.0 mg/ml (20,000ppm) >240 Cytarabine 100 mg/ml (100,000ppm) >240 Cytovene 10 mg/ml (10,000ppm) >240 Dacarbazine(DTIC) 10.0 mg/ml (10,000ppm) >240 Daunorubicin 5 mg/ml (5,000ppm) >240 Docetaxel 10.0 mg/ml(10,000ppm) >240 Doxorubicin Hydrochloride 2.0 mg/ml (2,000ppm) >240 Ellence 2 mg/ml (2,000ppm) >240 Etoposide(Toposar) 20.0 mg/ml(20,000ppm) >240 Fludarabine 25 mg/ml(25,000ppm) >240 Fluorouracil 50 mg/ml(50,000ppm) >240 Gemcitabine (Gemzar) 38 mg/ml(38,000ppm) >240 Idarubicin 1 mg/ml (1,000ppm) >240 Ifosfamide 50.0 mg/ml (50,000ppm) >240 Irinotecan 20.0 mg/ml (20,000ppm) >240 Mechlorethamine HCI 1.0 mg/ml (1,000ppm) >240 Melphalan 5 mg/ml (5,000ppm) >240 Methotrexate 25mg/ml (25,000ppm) >240 Mitomycin C 0.5 mg/ml (500 ppm) >240 Mitoxantrone 2.0 mg/ml(2,000ppm) >240 Oxaliplatin 2.0 mg/ml(2,000ppm) >240 Paclitaxel (Taxol) 6.0 mg/ml(6,000ppm) >240 Rituximab 10 mg/ml(10,000ppm) >240 Thiotepa 10.0 mg/ml (10,000ppm) 36.1 (51.2, 36.1, 45.6) Trisenox 0.1 mg/ml (100ppm) >240 Vincristine Sulfate 1.0 mg/ml (1,000ppm) >240 Vinorelbine 10 mg/ml(10,000ppm) >240 *Please note that the following drugs have low permeation times: Carmustine (BCNU): 8.5 minutes and Thiotepa: 36.1 minutes
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。